Short answer · Medically reviewed summary · Last updated: 2026-05-08
Carcinoid syndrome is diagnosed through a combination of biochemical testing, specifically measuring 24-hour urinary 5-HIAA levels, and advanced diagnostic imaging like CT, MRI, or specialized Gallium-68 DOTATATE PET scans. Because symptoms are often non-specific, reaching an accurate diagnosis can be challenging and typically requires evaluation by an endocrinologist or gastroenterologist specializing in neuroendocrine tumors. How is Carcinoid Syndrome diagnosed? The diagnostic process for Carcinoid Syndrome begins with clinical suspicion when a patient presents with hallmark symptoms like flushing, diarrhea, and wheezing.
1 people with Carcinoid Syndrome have shared their first-person experience on this question at DiseaseMaps.
How is Carcinoid Syndrome diagnosed?
How Carcinoid Syndrome is diagnosed: tests, specialists and the diagnostic journey, told by patients and reviewed against medical sources.
Carcinoid syndrome is diagnosed through a combination of biochemical testing, specifically measuring 24-hour urinary 5-HIAA levels, and advanced diagnostic imaging like CT, MRI, or specialized Gallium-68 DOTATATE PET scans. Because symptoms are often non-specific, reaching an accurate diagnosis can be challenging and typically requires evaluation by an endocrinologist or gastroenterologist specializing in neuroendocrine tumors.
How is Carcinoid Syndrome diagnosed?
The diagnostic process for Carcinoid Syndrome begins with clinical suspicion when a patient presents with hallmark symptoms like flushing, diarrhea, and wheezing. Because Carcinoid Syndrome is rare, it is frequently misdiagnosed as irritable bowel syndrome (IBS) or menopause. Physicians must confirm the presence of an underlying neuroendocrine tumor (NET) that has released vasoactive substances into the systemic circulation, often indicating that the tumor has metastasized to the liver.
What tests confirm Carcinoid Syndrome?
Clinicians utilize a specific diagnostic toolkit to confirm Carcinoid Syndrome, often moving through these steps:
- Biochemical Testing: Measuring 24-hour urine levels of 5-hydroxyindoleacetic acid (5-HIAA), a breakdown product of serotonin.
- Blood Tests: Measuring plasma chromogranin A (CgA) levels, which are often elevated in patients with Carcinoid Syndrome.
- Imaging Studies: Utilizing CT or MRI scans to locate the primary tumor, followed by functional imaging like Gallium-68 DOTATATE PET/CT scans, which are highly sensitive for detecting somatostatin receptor-expressing tumors.
- Biopsy: Histopathological examination of tumor tissue to confirm the grade and origin of the neuroendocrine tumor.
Why is the diagnostic odyssey so long?
Many of the 49 members in our Carcinoid Syndrome community report a significant "diagnostic odyssey," sometimes waiting years for a correct diagnosis. This occurs because the symptoms are intermittent and mimic common gastrointestinal or hormonal conditions. If your primary care provider is unfamiliar with Carcinoid Syndrome, it is vital to seek a referral to a high-volume center that specializes in neuroendocrine malignancies to prevent delays in essential treatment.
Next steps
- Consult with a gastroenterologist or endocrinologist specializing in neuroendocrine tumors.
- Request a 24-hour urine 5-HIAA test if you exhibit unexplained flushing and diarrhea.
- Connect with the Carcinoid Syndrome community at DiseaseMaps.org to share experiences and find regional specialists.
- Maintain a detailed symptom diary to help your medical team identify patterns.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Carcinoid Syndrome Overview.
- Orphanet: Neuroendocrine tumors and Carcinoid Syndrome.
- The Neuroendocrine Cancer Awareness Network (NCAN).
- PubMed: "Diagnosis and Management of Carcinoid Syndrome," Clinical Practice Guidelines.
Posted Sep 14, 2017 by Vickie 2000
